Aurinia Pharmaceuticals
Price & Volume
Stats
See more52W Range | $11.21-$19.25 |
Market Cap | $2.2B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $311.5M |
Revenue Growth (YoY) | 18.9% |
Gross Profit (12 Mos) | $242.6M |
Diluted EPS | $2.28 |
News
See moreYahoo Finance • last month
Immatics and 4 More Stocks See Action From Activist Investors
Yahoo Finance • 2 months ago
Aurinia settles Lupkynis patent litigation with Teva
Yahoo Finance • 4 months ago
Tang Capital takes 10% stake in Aurinia Pharma
Yahoo Finance • 7 months ago
Mutiny At Aurinia Pharmaceuticals? Biotech Soars On C-Suite Shake-Up.
About
CEO | Mr. Kevin C. Tang |
Address | #140, 14315 ? 118 Avenue, Edmonton, AB, Canada, T5L 4S6 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 128 |